{"id":"W3092236290","doi":"10.1186/s12885-020-07374-3","title":"Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin’s lymphoma: a probabilistic analysis","year":2020,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Occupational Cancer Research Centre; Canadian Centre for Applied Research in Cancer Control; Simon Fraser University","funders":"Canadian Institutes of Health Research; Genome British Columbia; Michael Smith Health Research BC; BC Cancer Foundation; Genome Canada","keywords":"ABVD; Brentuximab vedotin; Medicine; Dacarbazine; Hodgkin's lymphoma; Oncology; Chemotherapy regimen; Cost effectiveness; Cost-effectiveness analysis; Incremental cost-effectiveness ratio; Internal medicine; Cancer; Hodgkin lymphoma; Lymphoma; Chemotherapy; Vincristine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01035384,0.001083278,0.002011233,0.002244001,0.0004626016,0.001780998,0.001566863,0.001552786,0.005450092],"category_scores_gemma":[0.02864573,0.001011952,0.00486125,0.001942829,0.0007884139,0.001439653,0.001196618,0.001783437,0.0002746617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005509494,"about_ca_system_score_gemma":0.002879736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02253812,"about_ca_topic_score_gemma":0.01012495,"domain_scores_codex":[0.9965838,0.002365837,0.000117967,0.0002928821,0.0003614921,0.0002779547],"domain_scores_gemma":[0.9782707,0.01914501,0.001314751,0.0002996778,0.0006466865,0.0003231828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.001243535,0.000097482,0.006799159,0.0002636436,0.0006008215,0.0001152047,0.00003355559,0.9769356,0.0001278475,0.004885469,0.0006370644,0.008260648],"study_design_scores_gemma":[0.0003993594,0.0007068873,0.01032827,0.0002187869,0.001227081,0.0003220445,0.00006030961,0.9750718,0.0001581014,0.009967987,0.001476494,0.00006280399],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8750932,0.01188707,0.08128974,0.003710365,0.00008299409,0.00192318,0.009457042,0.0002577925,0.01629852],"genre_scores_gemma":[0.986935,0.001731351,0.00817465,0.0001822203,0.00002606957,0.0004220396,0.001531867,0.00002418159,0.0009726476],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02253812,"threshold_uncertainty_score":0.05475694,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0681199910779398,"score_gpt":0.3507224088310248,"score_spread":0.282602417753085,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}